Compugen (CGEN) Equity Income (2023 - 2025)
Compugen (CGEN) posted quarterly Equity Income of $56.8 million for Q4 2025, up 1029.3% year-over-year from $5.0 million in Q4 2024, and up 914.51% on a QoQ basis from -$7.0 million in Q3 2025.
Compugen (CGEN) Equity Income (2023 - 2025) Analysis & Trends
Compugen has reported Equity Income for 3 years, with the latest figure at $56.8 million in Q4 2025.
- Equity Income for Q4 2025 came in at $56.8 million, up 1029.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $45.0 million (up 1004.12% YoY), and the FY2025 annual result was $35.3 million, up 348.35% from the prior year.
- Equity Income climbed to $56.8 million in Q4 2025, from -$7.0 million in the prior quarter.
- Over five years, Equity Income peaked at $56.8 million in Q4 2025 and troughed at -$9.9 million in Q3 2023.
- A 3-year average of $7.5 million and a median of -$2.4 million in 2024 frame the typical range for Equity Income.
- The largest YoY upside for Equity Income was 1029.3% in 2025 against a maximum downside of 646.94% in 2025.
- A 3-year view of Equity Income shows it stood at $9.7 million in 2023, then slumped by 162.98% to -$6.1 million in 2024, then jumped by 1029.3% to $56.8 million in 2025.
- Per Business Quant data, the three most recent Equity Income figures were $56.8 million in Q4 2025, -$7.0 million in Q3 2025, and -$6.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.85 Mn |
| Sep 30, 2025 | -6.98 Mn |
| Dec 31, 2024 | -6.12 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Dec 31, 2023 | 9.71 Mn |
| Sep 30, 2023 | -9.85 Mn |